Chemicals

ChroMedX Engages Biosensor Development Expert Stephen Cozzette

January 26, 2015 5:00 PM

TORONTO, ONTARIO / ACCESSWIRE / January 26, 2015 / ChroMedX Corp. (CSE: CHX) (OTC: MNLIF) (EIY2.F) (the "Company"), a developer of in vitro diagnostics and point-of-care technologies is pleased to announce the engagement of Mr. Stephen Cozzette as a consultant on the HemoPalm project focussing on the electrochemical sensor and cartridge development aspects of the project. "We are very excited to add Stephens's expertise to the team. Mr....

Read more

ChroMedX Exhibits and Presents at Cantech ’15 in Toronto, Canada

January 13, 2015 3:24 PM

Toronto, Ontario / ACCESSWIRE / January 13, 2015 / ChroMedX Corp. (CSE: CHX) (OTC: MNLIF) (EIY2.F) (the "Company"), a developer of in vitro diagnostics and point-of-care technologies is pleased to announce that the Company will be presenting and exhibiting at the Cantech '15 Technology Conference on Thursday, January 15, 2015 in Toronto, Ontario Canada. ChroMedX President and CEO, Dr. Wayne Maddever, will be conducting a feature...

Read more

ChroMedX 2014 Progress Update

December 19, 2014 4:15 PM

Toronto, ON / ACCESSWIRE / December 19, 2014 / ChroMedX Corp. (CSE: CHX) (OTC: MNLIF) (EIY2.F) (the "Company"), a developer of in vitro diagnostics and point-of-care technologies is proud to report on the Company's corporate and developmental progress in 2014. ChroMedX listed in mid-July 2014 and has made significant progress in the development of its patented technologies as well as advancement of the Corporation as a public entity. "We...

Read more

Chromedx Completes Acquisition of Automated Ultrafiltration Immunoassay Technology

December 15, 2014 6:31 AM

Toronto, Ontario / ACCESSWIRE / December 15, 2014 / ChroMedX Corp. (CSE: CHX) (OTC: MNLIF) (EIY2.F) (the "Company"), a developer of in vitro diagnostics and point-of-care technologies is pleased to announce the it has closed its previously announced acquisition of patent application PCT/CA2013/050935 related to Automated Ultrafiltration Technology and associated intellectual property ("AUF") from InvidX Corp., pursuant to an option agreement...

Read more

ChroMedX Commences AUF Development with Aline Inc. and Spectrum Labs

December 9, 2014 4:30 PM

TORONTO, ON / ACCESSWIRE / December 9, 2014 / ChroMedX Corp. (CSE: CHX) (OTC: MNLIF) (EIY2.F) (the "Company"), a developer of in vitro diagnostics and point-of-care technologies is pleased to announce the engagement of ALine Inc. as primary contractor for the development of its recently acquired Automated Ultrafiltration (AUF) Cartridge. The AUF cartridge will be used as part of an automated system in the preparation of plasma/serum...

Read more

ChroMedX Acquires Automated Ultrafiltration Immunoassay Technology

November 28, 2014 3:53 PM

Toronto, ON / ACCESSWIRE / November 28, 2014 / ChroMedX Corp. (CSE: CHX) (OTC: MNLIF) (Frankfurt: EIY2) (the "Company"), a developer of in vitro diagnostics and point-of-care technologies is pleased to announce the acquisition of the Automated Ultrafiltration Technology "AUF" and associated intellectual property.  "After thorough investigation of the technology, potential market, and development requirements we are very enthused to add the AUF...

Read more

ChroMedX Announces Biosensor Development and HemoPalm Update

November 24, 2014 3:30 AM

Toronto, Ontario / ACCESSWIRE / November 24, 2014 / ChroMedX Corp. (the "Company") (CSE: CHX) (OTC: MNLIF) (Frankfurt: EIY2), a developer of in vitro diagnostics and point-of-care technologies is pleased to provide an update on the Company's HemoPalm handheld analyser/Cartridge technology and the commencement of biosensor development. Lead contractor, Aline Inc. has taken delivery of the first batch of biosensors in Rancho Dominguez, CA....

Read more

Chromedx Announces Collaborative Project with McMaster University

November 17, 2014 3:30 AM

Toronto, Ontario / ACCESSWIRE / November 17, 2014 / ChroMedX Corp. (CSE: CHX) (OTC: MNLIF) (Frankfurt: EIY2) (the "Company"), a developer of in vitro diagnostics and point-of-care technologies is pleased to announce that it has reached an agreement with McMaster University on a collaborative project. The collaborative Project led by ChroMedX Technical Advisory Board member Dr. Cynthia Balion will provide the necessary laboratory space...

Read more

ChroMedX Engages Dr. Hai Shiene Chen as Asia Business Development Advisor

November 11, 2014 3:30 AM

Toronto, Ontario / ACCESSWIRE / November 11, 2014 / ChroMedX Corp. (CSE: CHX) (OTC: MNLIF) (Frankfurt: EIY2) (the "Company"), is pleased to announce the engagement of Dr. Hai Shiene Chen of ACGT Corporation of Toronto, Ontario to assist the Company in the international commercialization of its innovative point of care and in-vitro diagnostics technologies in the Asian market. Dr. Chen will assist the Company by pursuing...

Read more

ChroMedX Announces Operations Update and Advisory Board Appointment

October 28, 2014 1:30 AM

Toronto, ON / ACCESSWIRE / October 28, 2014 / ChroMedX Corp. (CSE: CHX) (OTC: MNLIF) (Frankfurt: EIY2) (the "Company"), a developer of in vitro diagnostics and point-of-care technologies is pleased to provide a HemoPalm development update and announce Dr. Cynthia Balion as the first appointment to the Company's Technical Advisory Board. Dr. Wayne Maddever, P.Eng., Chief Executive Officer of ChroMedX Corp. is pleased to provide the...

Read more

ChroMedX Announces HemoPalm Trademark and Intellectual Property Update

October 23, 2014 3:30 AM

Toronto, Ontario / ACCESSWIRE / October 23, 2014 / ChroMedX Corp. (CSE: CHX) (OTC: MNLIF) (Frankfurt: EIY2) (the "Company"), a developer of in vitro diagnostics and point-of-care technologies is pleased to announce that the trademark for the Company's patented HemoPalm technology has been allowed by the United States Patent and Trademark Office and will be officially registered when the HemoPalm is released commercially. The HemoPalm...

Read more

ChroMedX Engages Witteveen as European Business Development Advisor

October 16, 2014 3:15 AM

Toronto, Ontario / ACCESSWIRE / October 16, 2014 / ChroMedX Corp. (CSE: CHX) (the "Company") is pleased to announce the engagement of European based Business Development Consultant Marco Witteveen to assist the Company in the international commercialization of its innovative point of care and in-vitro diagnostics technologies. Marco Witteveen received his B.A.Sc. in International Business and M.A.Sc degree in Strategic Sales Management in...

Read more

ChroMedX Corp Announces Grant of Options

October 6, 2014 3:26 PM

Toronto, ON / ACCESSWIRE / October 6, 2014 / ChroMedX Corp. (CSE: CHX) (OTC: MNLIF) (the "Company") announces that it has granted an aggregate of 600,000 options to purchase common shares of the Company exercisable at a price of $0.18 per share and expiring on October 6, 2017, to certain consultants of the Company. The consultants concerned bring expertise to the Company in several key areas. These include the electrochemical and...

Read more

ChroMedX Corp. Information to be Available through S&P Capital IQ Corporation Records Program

September 26, 2014 10:55 AM

TORONTO, ON / ACCESSWIRE / September 26, 2014 / ChroMedX Corp. (OTC: MNLIF) (CSE: CHX) announced today that its company information would be made available via S&P Capital IQ Corporation Records Listing Program. As part of the program, a full description of ChroMedX Corp. will be published in the Daily News Section of Standard & Poors's Corporation Records, a recognized securities manual for secondary trading in up to 38 States under the Blue...

Read more

Verde Science Forms R and D Alliance

September 23, 2014 11:11 AM

Richmond, BC / ACCESSWIRE / September 23, 2014 / Verde Science, Inc., (OTCQB: VRCI) a Medical Marijuana Research and Development Company with particular expertise in Aeroponic Growing Systems for the production of pure, efficacious Medical Marajuana, is pleased to announce a Research and Development Alliance with a Mumbai, India based pharmaceutical company that has a record of significant success in the development of novel medical treatment...

Read more

Monarch Energy Announces Results of Annual and Special Meeting

August 29, 2014 1:28 PM

Toronto, ON / ACCESSWIRE / August 29, 2014 / Monarch Energy Limited (CSE: CHX) (OTC: MNLIF) ("Monarch" or the "Company") announces that the shareholders of the Company have approved, at the Annual General and Special Meeting held on August 29, 2014, all of the items set forth in the Company's management information circular dated July 30, 2014 and mailed to the shareholders, including: (i) change of the Company's name to ChroMedX Corp.; (ii)...

Read more

Monarch Energy as ChroMedX Ltd. Engages ALine Inc. for Development of HemoPalm Cartridges and Handheld Analyzer

July 29, 2014 11:11 AM

Toronto, Ontario / ACCESSWIRE / July 29, 2014 / Monarch Energy Limited (CSE: CHX) (OTC: MNLIF) ("Monarch" or the "Company") is pleased to announce that its wholly-owned subsidiary ChroMedX Ltd. has engaged ALine Inc. of Rancho Dominguez, CA as its primary contractor for the development of the Company's HemoPalm cartridge and analyzer technology. The goal is to complete construction of the prototype cartridge and analyzer to demonstrate...

Read more

Municipal Approval for Lexaria-Enertopia Joint Venture in Burlington, Ontario

July 14, 2014 7:30 AM

Kelowna, British Columbia / ACCESSWIRE / July 14, 2014 / Lexaria Corp. (OTCQB: LXRP) (CSE: LXX) (the "Company" or "Lexaria") is pleased to announce that the production of Medical Marihuana in compliance with Health Canada MMPR regulations has received final Municipal zoning approval for the Lexaria/Enertopia joint venture. Previously announced only as being located in the Greater Toronto Area, now that Municipal approval has been obtained...

Read more

Gulf Resources to Host Third Quarter 2013 Earnings Webcast Live on Monday, November 11, 2013

November 11, 2013 2:00 AM

SHANDONG, CHINA - (ACCESSWIRE - November 8, 2013) - Gulf Resources, Inc.  (GURE) will host a live webcast to discuss the results of the third quarter 2013, to be held Monday, November 11, 2013 at 8:00 a.m. Eastern Time. This event will be broadcast live online at http://www.investorcalendar.com/IC/CEPage.asp?ID=171895. If you are unable to participate during the live webcast, the call will be available for replay at...

Read more